A 35-kDa polypeptide belonging to the high mobility group family of proteins was purified from the yeast Saccharomyces cerevisiae on the basis of its association with a DNA helicase activity. Amino acid sequence alignment suggests that this protein, Hmo1p, is related to the HMG1/2 class of chromatin-associated proteins. Consistent with this prediction, the Hmo1 protein immunolocalizes to the nucleus, binds single-stranded DNA, and unwinds DNA in the presence of eukaryotic DNA topoisomerase I. While the purified protein has no DNA helicase activity on its own, immunoprecipitation experiments confirm that Hmo1p associates with a 5 to 3 DNA helicase activity in nuclear extracts. The in vivo role of the protein was investigated by constructing an hmo1 deletion mutant. This strain has a severe growth defect, reduced plasmid stability, and chromatin that is hypersensitive to micrococcal nuclease digestion. Taken together, the data indicate that HMO1 is likely to be the homolog of HMG1/2 in higher cells and that it plays an important role in genome maintenance.
High mobility group (HMG) 1 proteins comprise a significant fraction of non-histone proteins of eukaryotic chromatin. They were originally discovered as abundant heterogeneous proteins that could be extracted from chromatin in 0.35 M NaCl and remain soluble in acid (1, 2) . Cloning of several genes encoding these proteins has revealed three types of HMGs that can be distinguished on the basis of their molecular weights, DNA binding characteristics, and amino acid sequence motifs, HMG-1/2, HMG-14/17, and HMG-I(Y) (2, 3) . Members of the HMG-1/2 type are distinguished by the presence of two copies of an 80-amino acid domain termed the "HMG Box" that are responsible for DNA binding activity (4) .
Proteins containing the HMG box now comprise a superfamily that can be divided into two classes, transcription factors and chromatin-associated proteins. Members of the transcription factor class usually contain a single box and recognize dsDNA with good sequence specificity (5) . The HMG box is present in a number of human sequence-specific transcription factors such as UBF, SRY, LEF-1, and TCF-1 (5) (6) (7) (8) . Members of the chromatin-associated class recognize DNA with little or no sequence specificity and instead recognize altered DNA conformations such as cruciforms (9) and DNA kinked by cisplatin (10) , as well as single-stranded DNA (11) . The chromatin-associated proteins have molecular masses of approximately 25 kDa, contain two HMG boxes, and a highly charged acidic C terminus. A general property of both classes of HMGs is the ability to bend or wrap DNA (12, 13) . Despite extensive biochemical study, the in vivo function of the chromatin-associated class of HMG box proteins is unclear. It is thought that they may play a general role in controlling chromatin structure and perhaps a specific role in controlling transcription and DNA replication (14, 15) .
The yeast system provides a powerful genetic tool to determine the role of these proteins in the cell, and a number of HMG-like proteins have been reported in yeast (16, 17) . Nonhistone proteins 6A and 6B are closely related 10-kDa proteins that contain a single HMG box and are encoded by the nonessential genes NHP6A and NHP6B (18) . Deletion of both genes confers a temperature-sensitive phenotype that can be rescued by the addition of sorbitol to the medium. Because of this and other phenotypes, it has been suggested that Nhp6p functions in the protein kinase C pathway controlling osmotic tolerance (19) . Abf2p (20) , or HM protein (21) , is a mitochondrial HMG protein containing two HMG boxes that is essential for maintenance of the mitochondrial genome (20) .
Here we report the biochemical purification and characterization of a predicted 27-kDa yeast protein, Hmo1p, that is related to higher-cell HMG1/2 proteins. Hmo1p is a nuclear protein that binds ssDNA and unwinds dsDNA similar to the chromatin-associated class of HMG proteins. Deletion of the HMO1 gene is not lethal to yeast but results in a severe growth defect and reduced plasmid stability. Chromatin isolated from the hmo1 mutant is hypersensitive to nuclease, consistent with Hmo1p playing a role in controlling chromatin structure. Thus, the hmo1 mutant may serve as a genetic system to study the role of HMG1/2 proteins of higher cells.
EXPERIMENTAL PROCEDURES
Strains and Media-Plasmid DNA was amplified in XL1-blue, and recombinant proteins were expressed in BL21(DE3) cells using the pET11a vector as described (22) . Yeast strain W303-1 was used for genetic manipulations, and protein was isolated from strain BJ5459 (23) . BJ5459 was grown in 600 liters of fermenter in YPD to A 600 ϭ 3, supplemented with 1% glucose, and harvested at A 600 ϭ 6. Cell paste was stored at Ϫ80°C.
Protein Purification-Whole cell yeast protein extract was prepared essentially as described (24) . All steps were performed on ice or at 4°C. About 400 g of yeast cells were suspended in 2 ϫ buffer B (1 ϫ ϭ 25 mM Hepes, pH 7.5, 1 mM EDTA, 1 mM DTT, 0.1 mM phenylmethylsulfonyl fluoride, 0.01% Nonidet P-40, and 10% glycerol) containing 1 mM benzamidine and 1 mM bacitracin, and broken by bead beater (Biospec Products, Bartlesville, OK). The lysate was extracted by stirring in 0.4 M ammonium sulfate for 1 h and centrifuged in a GSA rotor at 9000 rpm for 30 min to pellet insoluble components. The supernatant was then centrifuged at 44,000 rpm in a Beckman Ti45 rotor for 45 min. The cleared supernatant was brought to 65% saturatation with solid am-* This work was supported by Grant MCB-9304171 from the National Science Foundation. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ To whom correspondence should be addressed: Dept. of Molecular Biology and Biochemistry, Center for Advanced Biotechnology and Medicine, 679 Hoes Lane, Rutgers University, Piscataway, NJ 08855. Tel.: 908-235-4197; Fax: 908-235-4880; E-mail: brill@mbcl.rutgers.edu. 1 The abbreviations used are: HMG, high mobility group; PAGE, polyacrylamide gel electrophoresis; aa, amino acid; ssDNA, singlestranded DNA; dsDNA, double-stranded DNA; ARS, autonomously replication sequence; WT, wild-type; ORF, open reading frame; DAPI, 4,6-diamidino-2-phenylindole; DTT, dithiothreitol; PCR, polymerase chain reaction; kb, kilobase pair(s); PIPES, 1,4-piperazinediethanesulfonic acid. monium sulfate, and the resulting precipitate was pelleted. The pellet was resuspended in buffer B and dialyzed against 0.25 M NaCl in buffer B. The solution was cleared by centrifugation and loaded onto a 300-ml SP-Sepharose column pre-equilibrated with buffer B containing 0.25 M NaCl. The column was washed until A 280 approached base line and eluted with 2000-ml gradient 0.25-0.6 M NaCl in buffer B, followed by a 500-ml wash of 1.0 M NaCl in buffer B. The S4 fraction (450 -500 mM), which contained a major 5Ј-3Ј DNA helicase activity, was pooled, diluted 2-fold, and loaded onto a 20-ml ssDNA cellulose column. The column was washed with 3 column volumes of buffer B containing 0.2 mM NaCl, and then a 100-ml 0.2-0.8 M NaCl gradient in buffer B was applied. Multiple DNA helicase activities are identified on this gradient. The active 0.33-0.38 M fractions were pooled and dialyzed against buffer A (25 mM Tris, pH 8.0, 0.01% Nonidet P-40, 0.1 mM EDTA, 1 mM DTT, 0.1 mM phenylmethylsulfonyl fluoride, and 10% glycerol) containing 50 mM NaCl. Dialyzed material was loaded onto a Mono Q column (HR 10/10, Pharmacia Biotech Inc.). The column was developed with a 200-ml 0.05-0.45 M NaCl gradient in buffer A. DNA helicase activity was split into four fractions as follows: flow-through, 0.08 M, 0.16 M, and 0.32 M. The 0.16 M fraction was concentrated by binding to a 1.0-ml heparin column and eluting with a step wash of 1.0 M NaCl in buffer B. Concentrated protein was injected onto a 120-ml Superdex-200 column (HiLoad 16/60, Pharmacia) equilibrated with 0.2 M NaCl in buffer B. Active helicase fractions 38 -42 were pooled and loaded directly onto a Mono S column (HR 5/5, Pharmacia) and fractionated with a 0.3-0.6 M NaCl gradient in buffer B, pH 7.0. Aliquots from fractions of last two steps were checked by 12% SDS-PAGE and silver staining.
DNA Helicase Assay-A bidirectional DNA helicase substrate was designed using a modification of Wood et al. (25) . A 64-nucleotide oligomer, JL1 (GGCCAGTGAATTCGAGCTCGGTACCCGGGGATCCTCT-AGAGTCGACCTGCAGGCATGCAAGCTT), that complements the M13mp19 ssDNA cloning site was kinased with [␥-32 P]ATP and T4 polynucleotide kinase and annealed to M13 ssDNA. The partial duplex was labeled at its 3Ј end using Klenow enzyme and [␣-
32 P]dGTP. After phenol extraction and ethanol precipitation, the DNA was cut with SmaI. Excess oligo and free nucleotides were removed by Sepharose-6B gel filtration (5 ml). This procedure generates two labeled fragments, a 26-and a 40-mer, which anneal to the 5Ј and 3Ј ends, respectively, of linearized M13 ssDNA (Fig. 1B) . To assay, 2 l of each column fraction was incubated with substrate (5,000 -10,000 cpm/5 fmol/assay) for 30 min at 30°C in 25 mM Tris, 1 mM DTT, 5 mM MgCl 2 , 5 mM ATP (20 l final volume). Reactions were stopped with 5 l of stop solution (0.5% SDS, 50 mM EDTA, 50% glycerol) and immediately loaded onto a 12% polyacrylamide gel in 1 ϫ TBE and 0.1% SDS. The gel was run at 100 V for 3 h, fixed in 5% acetic acid, 40% methanol solution, dried, and autoradiographed. A unit of DNA helicase activity is defined as the amount of activity that is able to displace 50% of the probe (5 fmol total) in 30 min at 30°C.
Peptide Sequencing and Sequence Computer Analysis-Purified Hmo1 protein was excised from a Coomassie Blue-stained 15% SDS-PAGE gel, subjected to in-gel digestion with Achromobacter protease I, high performance liquid chromatography peptide mapping, and automated Edman degradation as described (26) . The BLAST program was used to find homologous sequences in GenBank. Protein sequence analysis was done using the GCG package (27) .
Plasmids Constructions-pJL11 was constructed by ligating a 2.1-kb PCR product of HMO1 into pRS415 (28) following digesting with BamHI and XhoI. The PCR fragment was obtained by amplification with oligonucleotides 216 (AGAGGATCCGGGAGCATCTCCAT-CAGCCG) and 217 (AGTCTCGAGGGCGAAGAGCATCCCAATTCG) using cosmid SC9395 as template. This fragment contains the entire ORF plus 0.6 kb each of upstream and downstream sequences. This same PCR product was ligated into pRS416 (28) to make pJL16 and into pLS300 (29) to make pJL13. A 505-base pair HpaI-KpnI fragment was removed from pJL13 (deleting most of the ORF) and replaced with a SmaI-KpnI fragment containing the TRP1 gene to make the disruption plasmid pJL15. pJL12 was constructed by ligating a 0.8-kb PCR fragment (with NdeI and BamHI ends) containing the entire ORF into pET11a (22) . HMO2 was amplified off cosmid SC8119 with oligonucleotides 253 (CCTAGAGCTCTGTATCTTGTGGGGTAGGTAAG) and 254 (GTACTCGAGGTGGCTTCTAAAGCTATTGTT). The 2.0-kb fragment was digested with SacI and XhoI and ligated into vector pSK (30) to yield pJL21. A 500-base pair BamHI-BglII fragment was removed from pJL21 and replaced with a LEU2 fragment to make the disruption plasmid pJL22. Cosmids were kindly provided by Linda Riles, Washington University.
Gene Disruption and Expression-HMO1, pJL15 was cut with BamHI and SpeI and used to transform W303 diploid yeast cells selecting for tryptophan prototrophy. HMO2, pJL22 was cut with SacI and XhoI and used to transform W303 diploid yeast cells selecting for leucine prototrophy. Southern blots verified that the appropriate mutations had been generated. Heterozygous diploids were sporulated and subjected to tetrad analysis. BL21(DE3) cells (22) transformed with pJL12 were grown in 2 liters of LB plus ampicillin to an A 600 of about 0.5 and induced with 0.4 mM isopropyl-1-thio-␤-D-galactopyranoside for 3 h. Bacteria were collected by centrifugation, resuspended in 1 ⁄10 volume buffer A (above) containing 50 mM NaCl and 1 mg/ml lysozyme. Following incubation on ice for 15 min, the sample was subjected to three cycles of freeze-thaw and sonicated 3 ϫ 1 min on ice. The sample was then centrifuged at 100,000 ϫ g for 30 min at 4°C. The lysate was fractionated on a 20 ml of SP-Sepharose column, a 5-ml ssDNA cellulose column, and a Superdex-200 column using the conditions described in the previous section. Hmo1p was followed by SDS-PAGE and Coomassie staining and was essentially pure following these three steps.
Antibody Production and Immunolocalization-Purified recombinant Hmo1 protein was used as antigen to raise a rabbit antiserum (Cocalico, Reamstown, PA). The initial inoculum was 150 g of protein in complete adjuvant. The rabbit was boosted with 100 g of protein at 2, 3, and 7 weeks. At 4 and 8 weeks, serum samples were tested for antibody titer by Western blot and determined to be specific for Hmo1p.
Indirect immunofluorescent staining was used to localize the Hmo1 protein essentially as described (31) . Wild-type and hmo1 mutant yeast cells were incubated overnight with 50-fold dilutions of antiserum and preimmune serum at room temperature and then washed with phosphate-buffered saline incubated with 1:100 fluorescence isothiocyanatelabeled goat anti-rabbit IgG (Sigma) for 2 h at room temperature in the dark. Cells were washed and stained with 1.0 g/ml DAPI dye for 5 min before covering in mounting solution (Immunomount, Sigma). Cells were photographed with a Nikon fluorescent microscope (Microphot-FXA).
Yeast Nuclei Preparation and Micrococcal Nuclease Digestion-Wildtype and mutant cell nuclei were purified as described (32) . Equal numbers of nuclei (2 ϫ 10 8 ) were digested at 30°C with micrococcal nuclease at 15 or 150 units/ml final concentration in SPC buffer (1.0 M sorbitol, 20 mM PIPES, and 0.1 mM CaCl 2 ). The reactions were stopped at different time points with 1% SDS, 1 M NaCl, and 20 mM EDTA. DNA was extracted with phenol and precipitated. After treatment with RNase A, the samples were electrophoresed on 0.8% agarose gels containing ethidium bromide.
Immunoprecipitation-1.0 ml of nuclei, prepared as above, was pelleted and successively extracted by 0.5 ml of B buffer containing 0, 500, and 2000 mM NaCl. Extractions were performed on ice for 30 min with occasional mixing. Supernatants from each extraction were dialyzed against B buffer containing 150 mM NaCl. These nuclear salt extracts were clarified by centrifugation and 50 l resolved by 15% SDS-PAGE before transfer to nitrocellulose membrane, and probing with antiHmo1p rabbit serum. To immunoprecipitate Hmo1p, 2 l of antiHmo1p serum was added to the remaining extract and incubated on ice for 1 h. Following another clarification spin, 50 l of 20% (v/v) protein A-Sepharose beads were added to the supernatant and incubated on ice for another hour with occasional mixing. The beads were then washed four times with B buffer containing 150 mM NaCl and assayed directly for DNA helicase activity as described above.
Determination of Plasmid Loss Rates-The isogenic yeast strains JLY5A (HMO1) and JLY5C (hmo1) were transformed with plasmids pDK243 and pDK368-7 (33) and grown in liquid medium lacking leucine to log phase. The initial fraction of cells that contained the plasmid (F i ) was determined by plating dilutions of the culture onto synthetic medium with or without leucine. After 15 doublings (28 h for JLY5A, 45 h for JLY5C) in YPD medium, the final fraction of cells containing the plasmid (F f ) was determined in the same way. The loss rate (L) was calculated as 1-10 m , where m ϭ {log(F f ) Ϫ log(F i )}/number of cell divisions.
DNA Unwinding Assay-Relaxed closed circular pRS413 (28) plasmid DNA was prepared by adding calf thymus topoisomerase I in 50 mM Tris, pH 7.5, 10 mM MgCl 2 , 50 mM KCl, 0.5 mM DTT, 0.1 mM EDTA, and 30 g/ml bovine serum albumin as described (34) . After 1 h at 37°C, 1-g aliquots of DNA were transferred into tubes containing different amounts of Hmo1 protein in the same buffer and incubated at 30°C for 1 h. Reactions were quenched by adding 5 ϫ stop buffer (6 mg/ml Pronase, 4% SDS, 40 mM EDTA) and incubating at 37°C for another hour. DNA was then phenol/chloroform-extracted, electrophoresed on a 1% agarose gel in TBE buffer at 45 V for 15 h, stained with ethidium bromide, and photographed.
RESULTS

Identification of Hmo1
Protein-Using a strand-displacement assay and gel exclusion chromatography, we searched for high molecular weight DNA helicase activities in the yeast Saccharomyces cerevisiae. Our probe contained two labeled DNA fragments (Fig. 1B) , allowing us to determine the polarity of translocation following polyacrylamide gel electrophoresis. An activity with a 5Ј to 3Ј polarity was identified and purified over several columns (see purification scheme in Fig. 1A) . Shown in Fig. 1C is an SDS-PAGE gel of fractions from a Superdex 200 sizing column. Comparison of this elution profile with the strand-displacement assay shown in Fig. 1D reveals a 35-kDa protein co-fractionating with DNA helicase activity. This sizing column predicts a native molecular mass of 330,000 Da indicating that the 35-kDa polypeptide must form an oligomeric complex in solution.
Although we suspected that the 35-kDa protein was too small to encode an ATP-dependent strand-displacement activity, we were unable to identify a larger polypeptide specifically co-fractionating with the helicase activity. The 35-kDa protein could not be separated from the helicase activity over a total of six steps including chromatography on phosphocellulose, heparin-Sepharose, and ATP-agarose. On this last step, the 35-kDa protein and DNA helicase activity co-eluted at 400 mM NaCl, suggesting a very tight association (data not shown). N-terminal sequencing of the 35-kDa protein failed, but internal amino acid sequencing of the cleaved polypeptide yielded three peptide sequences with exact matches (underlined in Fig.  2A ) to a single 246-aa ORF within the yeast genome data base near the ARG3R 3Ј region of CHRIV (S49770, SC9395.07). A BLAST search with this 246-aa ORF indicated a high similarity to the HMG1/2 class of non-histone chromosomal proteins and to another uncharacterized yeast ORF of 203 aa on CHRIV (S50980, SC8119.05c; see Fig. 3A for alignment). We have named these yeast genes HMO1 and HMO2, respectively, for their relationship to High MObility Group proteins of higher eukaryotes.
We proved that HMO1 encodes the 35-kDa polypeptide in our preparations by raising antibody to recombinant protein and demonstrating that it recognized native yeast Hmo1p. Fig.  2B shows an early step in the purification of this recombinant protein, again using chromatography on Superdex 200. The recombinant protein elutes from the column in a tight peak at fraction 41 (native M r ϭ 290,000) which is very similar in size to the yeast protein. Highly purified protein from both yeast and Escherichia coli gave positive reactions with the antiserum on immunoblots (Fig. 2C ). Purified recombinant Hmo1p had no detectable DNA helicase or ssDNA-dependent ATPase activity (data not shown).
Characterization of the HMO1 Gene and Mutant Phenotype- Fig. 3A presents an alignment of the Hmo1 and Hmo2 proteins along with several vertebrate and yeast HMG proteins. A consensus sequence derived from 12 HMG1/2 boxes (underlined in Fig. 3A) is included for comparison (35) . The Hmo protein sequences are somewhat diverged from the consensus, particularly in the N-terminal A box, where many of the conserved hydrophobic and charged residues have been replaced by unrelated residues. As with other HMG1/2 proteins, the second domain of the Hmo proteins shows a higher degree of identity with the consensus. affect its structure with a helix-breaking glycine residue. The B box insertion is somewhat similar in sequence (QKAGL) but occurs in a region between helices I and II. Some variability is known to exist in this region as most B boxes lack two residues, relative to A boxes, near this position.
Hmo1p and Hmo2p are basic proteins (pI values ϭ 9.29 and 8.06, respectively) with highly charged C termini. The B box in both proteins is followed by a number of acidic residues, albeit fewer than higher-cell HMGs. Hmo1p is larger than the typical HMG protein, in part due to an additional C-terminal 19 residues, of which 12 residues are lysine. No other HMG shows such a basic region on its C terminus. Fig. 3B schematizes the relationship between these proteins and illustrates the overall similarity in size and charge to HMG1/2 proteins.
We disrupted HMO1 and HMO2 to create the hmo1-1::TRP1 and hmo2-1::LEU2 alleles shown in Fig. 4B . These disruption alleles were independently transformed into a diploid yeast strain, and tetrads were analyzed following sporulation. Four viable spores were obtained in both cases suggesting that neither gene is essential for viability. The hmo2-1 mutant grew and mated like the wild-type strain with no apparent phenotype. However, as shown in Fig. 4A , hmo1-1 mutant spores gave rise to extremely small colonies. This difference in colony size was not due to a difference in time of germination as judged by visual inspection following tetrad dissection. Furthermore, the hmo1 mutant had a doubling time of 180 min in liquid YPD at 30°C, approximately twice that of wild-type cells (data not shown). This long doubling time is not due to poor viability as individual mutant cells from an hmo1 colony were microdissected, and all were found to be capable of forming colonies. Fluorescence activated cell sorter analysis was used to determine if the hmo1 mutants display a specific cell cycle defect. We found a relatively normal distribution of cells within the cell cycle (approximately 40% in G 1 and 60% in G 2 /M; data not shown), indicating that the slow growth phenotype of these cells is not due to expansion of a particular phase of the cell cycle. The slow growth of hmo1 mutants is also not due to any defects in mitochondrial function since they are able to grow on non-fermentable carbon sources (data not shown). Homozygous hmo1 mutant diploids sporulate normally, and the double mutant, hmo1 hmo2, is indistinguishable from hmo1 mutants, showing no synthetic phenotype.
To identify functionally important regions of the protein, we constructed three C-terminal truncations of Hmo1p and tested whether these mutant proteins could complement the slowgrowth phenotype of the hmo1-1 mutant strain. The hmo1-1 disruption mutant is transformed to wild-type growth with a plasmid expressing the full-length 246-aa protein (data not shown). Similarly, constructs expressing all but the entire charged region (aa 1-210) also complement the mutant phenotype. However, a truncation removing 30 aa from the C terminus of the B box (aa 1-148) is unable to complement the hmo1-1 mutation (data not shown). Thus, an intact HMG B box of Hmo1p is essential for function, whereas the highly charged C terminus is not required for a wild-type growth rate.
To determine whether the hmo mutants had additional phenotypes, we tested the ability of the hmo1-1 and hmo2-1 mutants to grow under a variety of conditions (data not shown). Both mutant strains were viable on synthetic minimal medium and at all temperatures tested (17-37°C). Under all conditions the hmo1-1 mutant strain displayed the same slow-growth phenotype. Wild-type, hmo1, and hmo2 mutant strains were streaked onto YPD plates, placed at 55°C for 10 min, and returned to room temperature. Each strain was able to recover from this heat shock with colonies arising at similar frequencies. Because the nhp6A nhp6B double mutant shows a defect in osmotic tolerance (19) , we tested whether the hmo1 mutant phenotype could be rescued by the addition of an osmotic stabilizer to the medium. When wild-type, hmo1, and hmo2 cells were streaked onto YPD plates containing 1 M sorbitol, no change in the relative growth rates were observed, indicating that the mutants are not defective in osmotic tolerance. The triple mutant nhp6A-⌬3::URA3 nhp6B-⌬3::HIS3 hmo1-1 was constructed and found to be viable with no apparent synthetic phenotype.
Finally, we measured the ability of the hmo1 mutant to A box and B box) . Abbreviations: h, hydrophobic; a, aromatic. Sequences were taken from GenBank: ScNHP6A (P11632), ScNHP6B (P11633), HsHMG1 (X12597), HsHMG2 (X62534), GgHMG1 (D14314), ScABF2 (M73753), ScHMO2 (S50980), and ScHMO1 (S49770). B, schematic alignment of HMG1/2 proteins. The two "HMG boxes" are labeled as A box and B box. Downstream of the B box in HMG1 is a basic region (shaded) followed by a strongly acidic region (filled). The Hmo proteins have only a weak acidic region (half-filled) while Hmo1p has a strong basic C terminus (shaded). stably maintain centromeric ARS plasmids and found that the hmo1 mutant consistently displayed a 3-4-fold increase in plasmid loss frequency compared to WT. Table I presents the plasmid-loss frequencies of plasmids bearing either a single ARS element (pDK243) or seven copies of the ARS element (pDK368-7). In this experiment the hmo1 mutant showed a 3.5-fold elevation of plasmid-loss rate compared with WT but only when the plasmid bore a single ARS element. Interestingly, the instability was corrected by increasing the number of origins on the plasmid.
Hmo1 Protein Has Properties Expected for an HMG1/2 Protein-
The antiserum raised against Hmo1p was used to localize the antigen within yeast cells by indirect immunofluorescence. We immuno-stained wild-type and hmo1 mutant cells while simultaneously staining DNA with DAPI (Fig. 5) . The wildtype cells displayed a strong fluorescence that co-localized with the nuclear DAPI staining. This signal was specific for Hmo1p because hmo1 disruption mutants lacked the nuclear signal. DAPI staining of the hmo1 mutant nuclei consistently appeared less intense and more diffuse than wild type, suggesting a change in nuclear structure. DAPI staining of these mutants also revealed the presence of mtDNA, confirming that Hmo1p is not required for maintenance of mtDNA.
We next tested whether Hmo1 protein could unwind, or wrap, double-stranded DNA (dsDNA) like HMG1/2 proteins from higher cells (13, 21, 36) . Pre-relaxed plasmid DNA was incubated with Hmo1p and eukaryotic DNA topoisomerase I and then de-proteinized. As detected by agarose gel electro- 1-6, or 7-12) . Nucleosomal DNA was then purified and resolved by agarose gel electrophoresis and stained with ethidium bromide.
TABLE I
Plasmid-loss frequencies for the WT and hmo1 mutant Strains JLY5A (HMO1) and JLY5C (hmo1) were transformed with the indicated plasmids, and plasmid loss frequencies of four independent colonies were determined as described under "Materials and Methods." The average plasmid-loss frequencies (per cell per generation) and standard deviation are presented. phoresis, the product DNA consists of a faster-migrating form of DNA (Fig. 6A) . Electrophoresis in the presence of choloroquine confirmed that these species were negatively supercoiled (data not shown). While increased negative superhelicity was obtained with higher levels of Hmo1 protein, very high concentrations of Hmo1 protein inhibited the unwinding reaction similar to what has been observed for yeast HM protein (21) and human mtTF1 (36) . Purified recombinant Hmo1p was equally active in this assay (data not shown).
To determine if the Hmo1 protein is involved in nuclear DNA packaging, we isolated nuclei from WT and hmo1 mutant strains, subjected each to digestion with micrococcal nuclease, and observed the size distribution of nucleosomal ladders from bulk chromatin. As shown in Fig. 6B , nucleosomal ladders from WT and hmo1 strains are similar, indicating that the primary organization of the chromatin (the linker and nucleosomal core DNA) is unaltered in the mutant. However, under conditions that gave optimal digestion with WT nuclei, hmo1 nuclei were overdigested. For example, when nuclei were digested with 150 units/ml micrococcal nuclease for 10 -40 min (see lanes 4 -6 in Fig. 6B ), the WT chromatin released a ladder of 2-5 nucleosomal bands while the mutant released a ladder of 0 -2 bands. At this level of nuclease the mutant core DNA shows progressive shortening. When digested with 10-fold lower levels of nuclease (Fig. 6B, lanes 7-12) the mutant chromatin released ladders of 1-5 nucleosomal units, whereas the WT chromatin was underdigested releasing no discernible ladder. The hypersensitivity of hmo1 chromatin was observed multiple times using two different preparations of nuclei. This phenotype indicates that Hmo1p does not affect the size or spacing of nucleosomal units but is likely involved in higher-order chromatin packaging, as loss of this protein increases the sensitivity of chromatin to nuclease digestion.
Hmo1 Protein Interacts with a DNA Helicase in Cell Extracts-To determine whether the co-purification of Hmo1p and a DNA helicase activity represented a meaningful interaction or a fortuitous result of chromatography, we tested whether we could immunoprecipitate the DNA helicase activity along with Hmo1 protein. As shown in Fig. 7A , no DNA helicase activity was immunoprecipitated from purified recombinant Hmo1p from E. coli (lane E), whereas a weak 5Ј to 3Ј DNA helicase activity was co-precipitated from Hmo1p purified from yeast (lane Y). Moreover, an Hmo1p-dependent co-precipitating activity was identified in crude extracts. Nuclei from WT and hmo1 strains were extracted with 0, 500, and 2000 mM NaCl, and the extracts were dialyzed and subjected to either immunoprecipitation and DNA helicase assay or Western blot. Both the DNA helicase activity (Fig. 7A) and Hmo1p (Fig. 7B) were optimally extracted from WT nuclei at 500 mM NaCl (lane 4), whereas neither were detected in an hmo1 deletion strain under identical conditions (lane 7). We conclude that the association of the DNA helicase with Hmo1p is not simply due to co-fractionation but that it most likely represents a biologically relevant interaction.
DISCUSSION
Compared with chromatin from higher cells, yeast chromatin contains highly acetylated core histones (37) , small linker DNA (38) , and it lacks typical heterochromatin (39) as well as a typical histone H1 (40) . Since it has been suggested that HMG1/2 proteins bind to the linker region of eukaryotic chromatin (41) (42) (43) , one might question whether yeast would even require an HMG1/2 protein. We have now identified the product of the HMO1 gene in yeast and shown it to be similar to HMG1/2 proteins of higher cells. Hmo1p is unlike the previously described yeast nuclear HMG proteins, Nhp6A and Nhp6B (18) , in that it is larger, it contains two HMG boxes, and it reveals a severe growth phenotype when deleted. Furthermore, the lack of a synthetic phenotype between NHP6 and HMO1 suggests that they have non-overlapping functions in the cell.
The level of amino acid sequence similarity between Hmo1p and higher-cell HMG1/2 proteins is low in two regions that may not be critical for function. First, the A box is highly diverged from the consensus, but this box tends to be more diverged from the consensus for all species studied, and second, the C terminus of Hmo1p has a long run of basic residues not found in other HMG1/2 proteins. At least in yeast, this C terminus is dispensible for function. By contrast, an intact B box, which is highly conserved in Hmo1p, is essential for function in vivo. Thus, the divergence from higher cell HMG1/2 proteins may be due to the lack of selective pressure. Perhaps most surprising is that each HMG box of Hmo1p contains a 5-aa insertion, relative to all other HMG1/2 proteins. The importance of these insertions and the highly diverged A box in Hmo1p function can now be tested by mutagenesis and domain swap experiments in yeast.
Our immuno-localization experiments showed that this predominantly nuclear protein had considerable cytoplasmic fluorescence. This signal is unlikely to be due to cross-reactions with cytoplasmic antigens since hmo1 deletion mutant cells show decreases in both the nuclear and cytoplasmic fluorescence. These results are consistent with the Hmo1p antigen being present in both the cytoplasmic and nuclear compartments as was observed for human HMG1/2 using immunofluorescence (1, 44) and cell fractionation (45) . While the biological significance of the presence of HMG1/2 protein in the cytoplasm is unknown, it is intriguing that a similar subcellular distribution is found in organisms as diverse as yeast and humans and suggests that a cytoplasmic reserve may be critical for HMG function.
Genetically, we have shown that Hmo1p is required for normal growth and plasmid maintenance, in addition to regulating the susceptibility of yeast chromatin to nuclease. As proposed in other systems, we suggest that Hmo1p binds to the small linker DNA of yeast, thereby stabilizing a higher-order chro- FIG. 7 . Hmo1p co-immunoprecipitates a DNA helicase activity from yeast nuclear extracts. A, WT or hmo1 mutant nuclei were extracted with either 0, 500, or 2000 mM NaCl (lanes 3-5, WT; lanes 6 -8 hmo1, respectively), and Hmo1p immunoprecipitated from the dialyzed extract was as described under "Materials and Methods." Immunoprecipitates were assayed directly for DNA helicase activity (arrow). S and D show the helicase probe before and after heat denaturation, respectively. Hmo1p purified from both E. coli (E) and yeast (Y) was also immunoprecipitated and assayed for DNA helicase activity. B, equal portions of purified protein (lanes 1 and 2) and salt extracts (lanes [3] [4] [5] [6] [7] [8] were directly immunoblotted to reveal levels of Hmop1 protein.
matin structure. This higher-order structure may be important for normal gene expression and/or DNA replication. Such a model explains how the loss of Hmo1p results in a change in nuclease sensitivity without affecting the chromatin's primary structure. Why then are deletions of HMO1 viable? It is likely that there are other proteins that can perform the essential function of Hmo1p in maintaining chromatin structure. However, these proteins may lack the abundance or binding properties to optimally replace loss of Hmo1p, resulting in the slow-growth phenotype. A search for genes that are synthetically lethal with the hmo1-1 mutation may identify other proteins involved in controlling chromatin structure.
Hmo1 mutant cells, which grow with a doubling time approximately twice that of wild-type, have a reduction in plasmid stability that can be reversed by the addition of extra origins of replication. Thus, it is possible that an altered chromatin structure in hmo1 mutants indirectly reduces the rate of initiation of DNA replication and inhibits the cell's growth. Such an effect would not be expected to be lethal in the genome due to the presence of multiple origins of replication per chromosome but would be expected to prolong S phase. That HMG proteins may serve a more direct role in the initiation of DNA replication is suggested by studies of Abf2p which was isolated as a yeast ARS-binding protein and demonstrated to bind a mtDNA element capable of functioning as an origin of DNA replication (20) . The effect on replication, however, may not entirely account for the slow-growth phenotype since we cannot exclude the possibility that other genomic processes, such as transcription, are changed in the mutant.
Hmo1p was identified biochemically due to its association with a DNA helicase activity, but as yet we have been unable to identify the polypeptide corresponding to the helicase. Given the negligible change in native molecular weight when Hmo1p is purified from bacteria, we conclude that only a substoichiometric amount of a potent helicase is associated with the Hmo1p complex. The interaction with a DNA helicase is likely to be meaningful given our ability to co-immunoprecipitate DNA helicase activity with Hmo1p from nuclear extracts. Moreover, it is possible that Hmo1p is stimulating the DNA helicase. As judged by the number of helicase units loaded onto an SDS-PAGE gel (more than 30 units at the peak in Fig. 1C ) and the sensitivity of our silver-staining method, we expected, but failed to detect, a polypeptide corresponding to the DNA helicase. In other studies, fewer than 10 similarly defined units of DNA helicase activity have revealed a silver-stainable polypeptide (46) . Because Hmo1p has a high affinity for ssDNA (it elutes from a ssDNA column at over 0.4 M NaCl), it may bind to the ssDNA products generated by a weak helicase resulting in an apparent stimulation of helicase activity. To test this idea recombinant Hmo1p, which is free of helicase activity, can be used to determine whether other helicase activities are stimulated in this manner. Alternatively, it should be possible to purify and identify the interacting helicase by Hmo1p proteinaffinity chromatography.
Taken together, our results suggest that Hmo1p may be the HMG1/2 homolog in yeast. Although a preliminary genetic complementation experiment with a human HMG2 clone failed (data not shown), we do not know if the hHMG2 protein was expressed in the yeast mutant. While more stringent genetic complementation experiments are required to prove an evolutionary relationship, the identification of a highly similar HMG protein in yeast has revealed an important role for these nuclear proteins in the growth of the cell. HMO1 now provides a genetic tool to study the function of these proteins in controlling higher-order chromatin structure. Biochemical studies in animal cells suggest that HMG1/2 proteins play general roles in transcription and DNA replication, yet specific functions for HMG proteins remain unknown. Further analysis of Hmo1p in yeast should shed light on the role of this protein family in controlling chromatin structure and genome maintenance in higher cells.
